All Stories

  1. Preparation and Preliminary Evaluation of 68 Ga-Acridine: An Attempt to Study the Potential of Radiolabeled DNA Intercalator as a PET Radiotracer for Tumor Imaging

    Article • Anti-Cancer Agents in Medicinal Chemistry, September 2020, Bentham Science Publishers

    Dr TAPAS DAS, Haladhar Dev Sarma

  2. 177 Lu-DOTMP induces G2/M cell cycle arrest and apoptosis in MG63 cell line

    Article • Journal of Labelled Compounds, July 2018, Wiley

    Dr TAPAS DAS

  3. Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study

    Article • Anti-Cancer Agents in Medicinal Chemistry, March 2018, Bentham Science Publishers

    Dr TAPAS DAS, Haladhar Dev Sarma

  4. The potential of radiolabeled chemotherapeutics in tumor diagnosis: Preliminary investigations with 68 Ga-gemcitabine

    Article • Drug Development Research, January 2018, Wiley

    Dr TAPAS DAS, Haladhar Dev Sarma

  5. Preparation and Evaluation of 177Lu-Labeled Gemcitabine: An Effort Toward Developing Radiolabeled Chemotherapeutics for Targeted Therapy Applications

    Article • Cancer Biotherapy & Radiopharmaceuticals, September 2017, Mary Ann Liebert Inc

    Dr TAPAS DAS, Haladhar Dev Sarma

  6. Radiochemical studies, pre-clinical investigation and preliminary clinical evaluation of 170 Tm-EDTMP prepared using in-house freeze-dried EDTMP kit

    Article • Applied Radiation and Isotopes, April 2017, Elsevier

    Dr TAPAS DAS, Haladhar Dev Sarma

  7. 170Tm-EDTMP

    Article • Clinical Nuclear Medicine, March 2017, Wolters Kluwer Health

    Dr TAPAS DAS

  8. Theranostic Treatment of Metastatic Bone Pain With 177Lu-DOTMP

    Article • Clinical Nuclear Medicine, December 2016, Wolters Kluwer Health

    Dr TAPAS DAS

  9. Preparation and preliminary bioevaluation of 68Ga-oxine in lipiodol as a potential liver imaging agent

    Article • Journal of Radioanalytical and Nuclear Chemistry, August 2016, Springer Science + Business Media

    Dr TAPAS DAS, Haladhar Dev Sarma

  10. Clinical translation of 177Lu-labeled PSMA-617: Initial experience in prostate cancer patients

    Article • Nuclear Medicine and Biology, May 2016, Elsevier

    Dr TAPAS DAS, Haladhar Dev Sarma

  11. Preparation and bioevaluation of [99mTcN]2+-labeled tetrameric complex of E-c(RGDfK)2 as a radiotracer for imaging αvβ3 integrins in tumors

    Article • Journal of Radioanalytical and Nuclear Chemistry, January 2016, Springer Science + Business Media

    Dr TAPAS DAS, Haladhar Dev Sarma

  12. Pharmacokinetic, Dosimetry and Toxicity Study of 177Lu-EDTMP in Patients: Phase 0/I study

    Article • Current Radiopharmaceuticals, November 2015, Bentham Science Publishers

    Prof C S Bal, Dr TAPAS DAS

  13. Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases

    Article • Journal of Nuclear Medicine, August 2015, Society of Nuclear Medicine

    Dr TAPAS DAS

  14. Estimation of specific activity of 177Lu by ‘saturation assay’ principle using DOTA as ligand

    Article • Current Radiopharmaceuticals, August 2015, Bentham Science Publishers

    Dr TAPAS DAS

  15. Formulation and evaluation of freeze-dried DOTMP kit for the preparation of clinical-scale 177Lu-DOTMP and 153Sm-DOTMP at the hospital radiopharmacy

    Article • Radiochimica Acta, January 2015, De Gruyter

    Dr TAPAS DAS, Haladhar Dev Sarma

  16. Formulation, Preclinical Evaluation, and Preliminary Clinical Investigation of an In-House Freeze-Dried EDTMP Kit Suitable for the Preparation of177Lu-EDTMP

    Article • Cancer Biotherapy & Radiopharmaceuticals, December 2014, Mary Ann Liebert Inc

    Dr AJIT S SHINTO, Dr TAPAS DAS, Haladhar Dev Sarma

  17. Formulation of Patient Dose of177Lu-DOTA-TATE in Hospital Radiopharmacy in India: Preparation UsingIn SituMethodology Vis-a-Vis Freeze-Dried Kit

    Article • Cancer Biotherapy & Radiopharmaceuticals, September 2014, Mary Ann Liebert Inc

    Dr TAPAS DAS

  18. Preparation of Therapeutic Dose of 177Lu-DOTA-TATE Using a Novel Single Vial Freeze-dried Kit: A Comparison with ‘In-situ’ Preparation at Hospital Radiopharmacy

    Article • Current Radiopharmaceuticals, August 2014, Bentham Science Publishers

    Dr AJIT S SHINTO, Dr TAPAS DAS

  19. Radiosynthesis and Bioevaluation of [68Ga]-Labeled 5,10,15,20-Tetra(4-methylpyridyl)-porphyrin for Possible Application as a PET Radiotracer for Tumor Imaging

    Article • Molecular Imaging and Biology, July 2014, Springer Science + Business Media

    Dr TAPAS DAS, Haladhar Dev Sarma

  20. 177Lu-EDTMP for Treatment of Bone Pain in Patients with Disseminated Skeletal Metastases

    Article • Journal of Nuclear Medicine Technology, February 2014, Society of Nuclear Medicine

    Dr TAPAS DAS

  21. Preparation of DOTA-TATE and DOTA-NOC freeze-dried kits for formulation of patient doses of 177Lu-labeled agents and their comparison for peptide receptor radionuclide therapy application

    Article • Journal of Radioanalytical and Nuclear Chemistry, January 2014, Springer Science + Business Media

    Dr AJIT S SHINTO, Dr TAPAS DAS

  22. Cellular Toxicity and Apoptosis Studies in Osteocarcinoma Cells, a Comparison of 177Lu-EDTMP and Lu-EDTMP

    Article • Current Radiopharmaceuticals, October 2013, Bentham Science Publishers

    Dr TAPAS DAS

  23. ‘Reverse discordance’ between 68Ga-DOTA-NOC PET/CT and 177Lu-DOTA-TATE posttherapy scan

    Article • Nuclear Medicine Communications, July 2011, Wolters Kluwer Health

    Dr TAPAS DAS

  24. 170Tm-EDTMP: a potential cost-effective alternative to 89SrCl2 for bone pain palliation

    Article • Nuclear Medicine and Biology, July 2009, Elsevier

    Dr TAPAS DAS, Haladhar Dev Sarma

  25. Comparative studies of 177Lu–EDTMP and 177Lu–DOTMP as potential agents for palliative radiotherapy of bone metastasis

    Article • Applied Radiation and Isotopes, September 2008, Elsevier

    Dr TAPAS DAS, Haladhar Dev Sarma

  26. 177Lu-EDTMP: A Viable Bone Pain Palliative in Skeletal Metastasis

    Article • Cancer Biotherapy & Radiopharmaceuticals, April 2008, Mary Ann Liebert Inc

    Dr TAPAS DAS, Haladhar Dev Sarma

  27. 177Lu-DOTMP: A viable agent for palliative radiotherapy of painful bone metastasis

    Article • Radiochimica Acta, January 2008, De Gruyter

    Dr TAPAS DAS, Haladhar Dev Sarma

  28. On the preparation of a therapeutic dose of 177Lu-labeled DOTA–TATE using indigenously produced 177Lu in medium flux reactor

    Article • Applied Radiation and Isotopes, March 2007, Elsevier

    Dr TAPAS DAS

  29. A novel [186/188Re]-labelled porphyrin for targeted radiotherapy

    Article • Nuclear Medicine Communications, October 2001, Wolters Kluwer Health

    Dr TAPAS DAS

  30. Potential 166Ho radiopharmaceuticals for intravascular radiation therapy (IVRT)-I : [166Ho] holmium labeled ethylene dicysteine

    Article • Nuclear Medicine and Biology, April 2001, Elsevier

    Dr TAPAS DAS

  31. [186/188Re] rhenium-ethylene dicysteine (Re-Ec): preparation and evaluation for possible use in endovascular brachytherapy

    Article • Nuclear Medicine and Biology, February 2000, Elsevier

    Dr TAPAS DAS